AI assistant
AMGEN INC — Director's Dealing 2014
Apr 29, 2014
29819_dirs_2014-04-29_69307e9a-3efd-48e2-9d18-4fe1a1788348.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2014-04-25
Reporting Person: Michael A Kelly (Acting CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-04-25 | Common Stock | F | 174 | $113.72 | Disposed | 42740 | Direct |
| 2014-04-25 | Common Stock | A | 628 | — | Acquired | 43368 | Direct |
| 2014-04-26 | Common Stock | F | 116 | $111.41 | Disposed | 43252 | Direct |
| 2014-04-27 | Common Stock | F | 140 | $111.41 | Disposed | 43112 | Direct |
| 2014-04-27 | Common Stock | F | 6 | $111.41 | Disposed | 43106 | Direct |
| 2014-04-28 | Common Stock | S | 2065 | $110.4466 | Disposed | 41041 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 183.4879 | Indirect |
Footnotes
F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/25/2016, 4/25/2017 and 4/25/2017.
F2: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 508 RSUs which vest in one installment on 4/25/2015; 804 RSUs which vest in two annual installments of 396 on 4/27/2015 and 408 on 4/27/2016; 780 RSUs which vest in two equal installments of 257 each on 4/26/2015 and 4/26/2016 and one installment of 266 on 4/27/2017; 8,406 RSUs which vest in two equal installments of 4,203 each on 6/30/2014 and 6/30/2015; and 628 RSUs which vest in two equal installments of 207 each on 4/25/2016 and 4/25/2017 and one installment of 214 on 4/25/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F3: These shares include 87 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share interest.
F4: These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.